Human recombinant soluble ACE2 in severe COVID-19
Alexander Zoufaly, Marko Poglitsch, Judith H. Aberle, Wolfgang Hoepler, Tamara Seitz, Marianna Traugott, Alexander Grieb, Erich Pawelka, Hermann Laferl, Christoph Wenisch, Stephanie Neuhold, Doris Haider, Karin Stiasny, Andreas Bergthaler, Elisabeth Puchhammer-Stoeckl, Alì Mirazimi, Núria Montserrat, Haibo Zhang, Arthur S. Slutsky, Josef Penninger
Topics & Concepts
Angiotensin-converting enzyme 2Peptidyl-Dipeptidase ARenin–angiotensin systemAngiotensin IIRecombinant DNACoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorCoronavirusEnzymeMedicineAngiotensin-converting enzymeVirologyPharmacologyChemistryBiologyInternal medicineBiochemistryDiseaseGeneInfectious disease (medical specialty)Blood pressureSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction